Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function.

Arun Rajasekaran, Naveen Bade, Gary R Cutter, Dana V Rizk, Abolfazl Zarjou

Journal: The American journal of the medical sciences 2022;364(4):433-443

PMID: 35490704

Abstract

BACKGROUND

Emerging evidence supports the superiority of balanced crystalloids such as Lactated Ringer's (LR) compared to normal saline but concerns for the development of hyperkalemia have limited its use. Although LR inherently contains potassium, there exists a paucity of evidence to suggest that LR could potentiate hyperkalemia. To address this, we evaluated the effect of LR on serum potassium in patients with reduced kidney function who are at risk of developing hyperkalemia.

METHODS

We conducted a single-center, retrospective cohort-based observational clinical study that included 293 clinical encounters who were hospitalized with an estimated glomerular filtration rate (eGFR) of < 30 ml/min/1.73m, at the time of hospital admission. Subjects must have received a minimum of 500 ml of LR continuously during the admission. Only those with a minimum of one lab report within 24 hours prior to-, and post-LR administration that reported serum measurements of potassium, glucose, and bicarbonate levels were included. Other potential risk factors for developing hyperkalemia including medication, tube feeds, potassium supplements, and red blood cell transfusion during or within 24 hours after LR administration were recorded.

RESULTS

Serum potassium prior to LR use was highly correlated and predictive of the serum potassium after LR use [P < 0.0001; Odds Ratio 6.77 (3.73 - 12.28)]. Sixteen encounters (5%) developed de-novo hyperkalemia following LR use. No significant positive correlation between the amount of LR administered and the development of hyperkalemia was found.

CONCLUSIONS

LR use was not independently associated with the development of hyperkalemia in patients with reduced kidney function.

Copyright © 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Address: Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: [email protected].; Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: [email protected].; Department of Biostatistics, University of Alabama, Birmingham, AL, USA. Electronic address: [email protected].; Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: [email protected].; Division of Nephrology, Department of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.